Related Experiment Video
Updated: Jun 21, 2025

14:32
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
23.6K
Pharmacist roles in the Medication Use Process: Qualitative analysis of stakeholder perceptions
Journal of the American Pharmacists Association : Japha
|July 13, 2024
Summary
Stakeholder perceptions of pharmacist roles in the Medication Use Process (MUP) have evolved, showing increased awareness beyond dispensing. However, pharmacists face challenges like burnout not recognized by patients and physicians.
Area of Science:
- Pharmacy Practice
- Healthcare Delivery
- Interprofessional Collaboration
Background:
- Pharmacist roles in the Medication Use Process (MUP) have advanced with new healthcare models.
- It remains unclear if stakeholder perceptions of these evolving roles have kept pace.
Purpose of the Study:
- To examine patient, pharmacist, and physician perceptions of pharmacist roles within the MUP.
- To identify areas of role congruence and divergence among key stakeholders.
Main Methods:
- Cross-sectional study utilizing Qualtrics panels for patients, pharmacists, and physicians.
- Role Theory framework informed 12-item surveys assessing perceptions across MUP stages.
- Content analysis of open-ended responses to identify recurring themes.
Main Results:
- Recurring themes included "pharmacists," "physicians," "insurance," "technology," "collaboration," "time," "communication," and "patient's responsibility."
- All stakeholders recognized pharmacists' roles in improving MUP stages, except transcribing.
- Pharmacists reported professional challenges (staffing, burnout) not perceived by patients and physicians.
Conclusions:
- Study indicates increased stakeholder awareness of pharmacists' expanded MUP roles beyond dispensing.
- Barriers like provider status and reimbursement were not reported by participants.
- Continuous advocacy and marketing are needed to inform stakeholders of pharmacists' evolving MUP contributions.
More Related Videos
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
Pharmacovigilance
815
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
815
Drug Administration and Therapy Phases: Overview
446
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
446
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Drug Control Governance: Regulatory Bodies and Their Impact
150
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
150
Pharmacokinetic Models: Overview
647
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
647

